|Articles|April 1, 2004
Mohs first line of therapy for non-melanoma eyelid tumors
Wailea, Hawaii - After reviewing more than 100 previous studies regarding different modalities for treating non-melanoma eyelid tumors, the evidence-based results clearly point to Mohs micrographic surgery as the formidable first line of therapy, according to Harry H. Sharata, M.D., Ph.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
Expert Panel Unanimously Backs DecisionDx-Melanoma for Guiding Personalized Cancer Care
4
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
5













